Cholesterol Test Market Forecast Covering Industry Demand And Market Evolution

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Cholesterol Test Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The cholesterol test market has experienced robust expansion in recent times. Its value is anticipated to climb from $9.94 billion in 2025 to $10.8 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. This past growth is largely due to the increasing prevalence of cardiovascular diseases, heightened awareness of cholesterol monitoring, the broadening of diagnostic laboratory networks, a rise in preventive healthcare screening, and the availability of affordable test kits.

The cholesterol test market is projected to experience substantial expansion over the upcoming period. This market is anticipated to reach $15.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. The expansion during this forecast timeframe is driven by factors such as a heightened demand for self-monitoring diagnostic instruments, an increased emphasis on detecting diseases early, the proliferation of remote patient testing options, the escalating integration of digital health platforms, and the wider embrace of personalized healthcare diagnostics. Key trends anticipated during the forecast period involve the growing acceptance of home-based cholesterol testing kits, an escalating need for point-of-care lipid testing equipment, the broader application of multi-parameter lipid panels, the scaling up of preventive cardiovascular screening initiatives, and a sharpened concentration on obtaining swift and precise test outcomes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11968&type=smp

What Primary Factors Are Fueling The Expansion Of The Cholesterol Test Market?

The projected increase in the occurrence of cardiovascular diseases is anticipated to accelerate the expansion of the cholesterol test market. Cardiovascular diseases (CVDs) refer to a range of ailments impacting the heart and blood vessels, including conditions like coronary heart disease, stroke, peripheral arterial disease, and aortic disease. A cholesterol test furnishes individuals and medical practitioners with essential data concerning the probability of developing heart disease. For example, in August 2025, as per the National Institutes of Health, a US-based government agency, it is projected that between 2025 and 2050, cardiovascular prevalence will rise by 90%, mortality by 73%, and DALYs by 55%, with fatalities increasing from 20.5 million to 35.6 million. Hence, the escalating death rates and prevalence of cardiovascular diseases will stimulate the cholesterol test market.

How Does Segment Analysis Break Down The Cholesterol Test Market Structure?

The cholesterol test market covered in this report is segmented –

1) By Product Type: Test Kits, Test Strips, Other Product Types

2) By Test Type: Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol, Triglycerides Or Very Low-Density Lipoprotein (VLDL) Cholesterol Test

3) By Distribution Channel: Over The Counter, Prescription Based

4) By End User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By Test Kits: Home Testing Kits, Laboratory Testing Kits

2) By Test Strips: Disposable Test Strips, Multi-Use Test Strips

3) By Other Product Types: Point-Of-Care Testing Devices, Cholesterol Monitors, Reagents And Calibration Solutions

Which Trends Are Contributing To Changes In The Cholesterol Test Market?

Major companies in the cholesterol test market are concentrating on creating innovative solutions, such as sophisticated blood testing systems, to improve the early identification and tracking of cholesterol levels. These initiatives aim to better patient outcomes, facilitate personalized treatment plans, and bolster preventive healthcare efforts. A blood testing system is a comprehensive setup or platform used to examine blood samples for various components, markers, or conditions. For instance, in March 2024, Babson Diagnostics, Inc., an Austrelia-based healthcare technology startup, introduced the BetterWay system. This innovative blood testing solution incorporates the MiniDraw device for fingertip sample collection. The system operates by warming the patient’s hand, collecting a pea-sized blood sample using a lancet-equipped device, and then automating sample preparation, including mixing and temperature regulation, before dispatching it to Babson’s lab for analysis. BetterWay can measure cholesterol, blood cell counts, and liver, kidney, and thyroid function from a minimal blood sample, providing results in one to two days while significantly enhancing patient comfort and convenience. This method effectively bridges the divide between conventional lab-based testing and accessible point-of-care solutions, thereby improving routine cholesterol monitoring.

Who Are The Leading Firms Participating In The Cholesterol Test Market?

Major companies operating in the cholesterol test market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers GmbH, Fujifilm Holdings Corporation, CVS Health Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Mindray Medical International Limited, SYNLAB International GmbH, Beckman Coulter Inc., PerkinElmer Inc., Horiba Ltd., Sigma-Aldrich Corp, Randox Laboratories Ltd., Nova Biomedical Corp, Abcam plc, Sinocare Inc., ACM Global Laboratories, Clinical Reference Laboratory Inc., Sekisui Diagnostics LLC, Everlywell Inc., SpectraCell Laboratories Inc., LetsGetChecked USA, Ulta Lab Tests LLC, Cell Biolabs Inc., BioReference Health LLC, Diazyme Laboratories Inc.

Access The Complete Cholesterol Test Market Report:

https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report

Which Region Is The Primary Market For The Cholesterol Test Market?

North America was the largest region in the cholesterol test market in 2025. The regions covered in the cholesterol test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cholesterol Test Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=11968&type=smp

Browse Through More Reports Similar to the Global Cholesterol Test Market 2026, By The Business Research Company

Pruritus Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

Pompe Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pompe-disease-global-market-report

Hidradenitis Suppurativa Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hidradenitis-suppurativa-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795